|Bid||0.3850 x 0|
|Ask||0.3950 x 0|
|Day's Range||0.3800 - 0.4000|
|52 Week Range||0.2500 - 1.0800|
|Beta (3Y Monthly)||1.63|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce an expansion of its operations with a new manufacturing facility in close proximity to the Toronto Herbal Remedies Inc. (“THR”) (the Company’s wholly-owned licensed cannabis producer) production facility in Scarborough, Ontario. The additional property allows the Company to continue to centralize operations in the Greater Toronto Area, as well as providing manufacturing capabilities for it’s proprietary reagents, a key input for the APP Technology cannabinoid recovery process. As Sproutly continues to explore other global markets for expansion, the need to produce its proprietary reagents at one central location and under EU GMP guidelines will be critical to ensuring consistency and quality, while at the same time reducing manufacturing costs.
A desire to move away from smoking may be fueling growth in the edible cannabis products. The shift toward edibles is a direct response to the decrease in smoking. Cannabis legalization has arrived just as tobacco smoking is seeing a steep decline.
NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Sproutly Canada Inc. (SRUTF) (CSE:SPR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. As the legal boundaries of the North American cannabis industry expand, businesses are looking for ways to make the most of their products and reach the widest possible market. Instead, companies are increasingly focused on alternatives such as edible cannabis products.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) announced today that Infusion Biosciences Inc. (“Infusion”) and BNO Holdings Inc. (“BNO Holdings”) have developed and verified analytical methods that detect, identify, and measure cannabinoid molecules in water-soluble (“Infuz2O”) and oil preparations (“Bio-Natural Oil”) derived from cannabis and hemp using APP Technology (collectively, the “Developed Analytics”). APP Technology is a patent pending process that uses proprietary reagents to recover naturally occurring water-soluble cannabinoids as well as the cannabis oils.
The newly legal Canadian cannabis market is a rapidly-developing frontier that analysts unanimously ...
As countries around the world begin to lift a nearly century-long prohibition on cannabis, products ...